Next |
home / stock / pali / pali message board
Subject | By | Source | When |
---|---|---|---|
bs you out with a loss mtf | peterus | investorshub | 04/06/2023 8:09:43 PM |
Out with small win,next | 81vette | investorshub | 04/06/2023 3:59:05 PM |
Beautiful bottom nab,big accumulation started on 30th, institutional/insider | 81vette | investorshub | 04/05/2023 4:10:49 PM |
News out,phase 3 trial,float 1.36m,short 10%(152,545 shares)ZERO BORROW,(no | 81vette | investorshub | 04/05/2023 4:04:38 PM |
I like the chart. | traderbbc1 | investorshub | 04/04/2023 11:08:35 PM |
pali vs Ther | Jayzp | investorshub | 04/04/2023 10:37:49 PM |
What is the target price for Palisade | skichic | investorshub | 04/03/2023 9:40:57 PM |
Made money selling friday premarket at 3.60s bought | enthalpy | investorshub | 04/03/2023 8:29:50 PM |
fda news in Q2 WILL GO BACK up | peterus | investorshub | 04/03/2023 6:25:44 PM |
That multiplies shares by 50% ruces price 1.75 | IOUBLOKE1 | investorshub | 04/03/2023 6:15:21 PM |
https://stockcharts.com/h-sc/ui?s=pali&p=D&yr=0&mn=6&dy=0&id=p38090673899 htt | surf1944 | investorshub | 04/03/2023 2:22:53 PM |
offering f$cking clowns | peterus | investorshub | 04/03/2023 12:36:09 PM |
PALI: So, PALI wants a KRACKER[/color | Invest-in-America | investorshub | 04/02/2023 3:49:13 PM |
PALI OS 4,503,977 | WHIP THE HORSE | investorshub | 04/01/2023 3:44:13 PM |
znewcar1: $PALI 32% v40,8M c3.52 f4,504M H3.65 ML1.55=LL gapNhod | znewcar1 | investorshangout | 04/01/2023 3:17:59 AM |
to many shorts and fliptards maybe dip AH | peterus | investorshub | 03/31/2023 7:49:48 PM |
would be nice to see a close +4 | peterus | investorshub | 03/31/2023 7:30:14 PM |
PH AH let see | peterus | investorshub | 03/31/2023 7:28:48 PM |
could do 30s with low float | peterus | investorshub | 03/31/2023 7:26:42 PM |
15 | peterus | investorshub | 03/31/2023 7:25:50 PM |
News, Short Squeeze, Breakout and More Instantly...
Palisade Bio Inc. Company Name:
PALI Stock Symbol:
NASDAQ Market:
– Company on track to commence Phase 1 human clinical study of lead product candidate, PALI-2108, for the treatment of Ulcerative Colitis (UC) before year end – Sufficient cash on hand to execute on business plan and reach clinical and regulatory milestones into 2025 ...
Jet.AI Inc. (JTAI) is expected to report for Q1 2024 Forian Inc. (FORA) is expected to report $-0.02 for Q1 2024 Square Enix Holdings Co. Ltd (SQNXF) is expected to report for Q4 2024 Qutoutiao Inc. (QTT) is expected to report for Q4 2023 Molecular Partners AG (MOLN) is expected t...
Wall Street and biotech industry veteran with expertise across corporate finance, business development, M&A, licensing, and strategic alliance transactions, globally Carlsbad, CA, May 07, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisadeȁ...